The global live cell encapsulation market was valued at USD 250 million in 2018 and is projected to reach USD 303 million by 2024, at a CAGR of 3.2% during the forecast period. The rising number of target patient population, increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical efficacy data of encapsulated cells in disease management are the major factors driving the growth of the live cell encapsulation market.
The global live cell encapsulation market is segmented based on manufacturing technique, polymer type, application, and region. Based on manufacturing technique, the market is segmented into simple dripping, electrostatic dripping, coaxial airflow, liquid-jet break-up, vibrating-jet technique, jet cutting, and rotating disk atomization. The electrostatic dripping segment is expected to witness the highest growth rate during the forecast period primarily due to its procedural benefits, such as the capability to manufacture small-sized particles, uniform size distribution, and retention of cell viability & potency.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218019375
Based on polymer type, the live cell encapsulation market is segmented into alginate, HEMA-MMA (hydroxyethyl methacrylate-methyl methacrylate), chitosan, siliceous encapsulates, cellulose sulfate, PAN-PVC [poly (acrylonitrile vinyl chloride)], and other polymers. The alginate segment is expected to register the highest growth rate during the forecast period. The high growth of this polymer type segment can be attributed to the procedural benefits offered such as capability to encapsulate living cells with wide pore size distribution (5–200 nm), and high permeability of alginate.
Based on application, the live cell encapsulation market is classified into drug delivery, regenerative medicine, cell transplantation, probiotics, and research. Probiotics is expected to be the fastest-growing application segment in the market owing to increasing adoption of cell encapsulation in the food processing industry and the health advantages offered such as alleviation of lactose malabsorption, cancer suppression, resistance to infectious gastrointestinal diseases, and improved digestion.
The global live cell encapsulation market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The North America market is estimated to register the highest growth rate during the forecast period majorly due to the increasing research activities in the field of cell encapsulation coupled with the growing public-private investments for cell encapsulation research practices and the increasing prevalence of chronic diseases such as diabetes, liver failure, and pancreatic cancers. Owing to the high-growth potential of the region, leading product manufacturers are undertaking strategic initiatives such as product commercialization to maintain their major market position.
